Once yearly zoledronic acid after 18 months of parathyroid hormone (1-84) for severe osteoporosis
| Data(s) |
2012
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_3D5DF4C66217 isbn:0937-941X isiid:000309259600222 http://my.unil.ch/serval/document/BIB_3D5DF4C66217.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3D5DF4C662175 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium |
| Tipo |
info:eu-repo/semantics/conferenceObject inproceedings |
